Sale!

Olopatadine 5 ML · Vial / Bottle

Winolap 5 Ml

Rx (Prescription Medicine)

Original price was: USD $ 25.00.Current price is: USD $ 20.00.

You save USD $ 5.00 (20%)

USD $ 4.00 per eye drop

Upload prescription Ask about this medicine
  • Dispatched from licensed pharmacy partners
  • Tracked worldwide shipping
  • Secure payment

Key facts

Active ingredient
Olopatadine
Strength
5 ML
Form
Eye Drops
Drug class
Generic
Brand
Winolap
Manufacturer
Sun Pharmaceutical Industries Ltd.
Pack sizes
5 ML

Description

Winolap 5 ml Eye Drops (Olopatadine Hydrochloride Ophthalmic Solution 0.1% w/v) is a high-efficacy, dual-action therapeutic formulation manufactured by Sun Pharmaceutical Industries Ltd. Designed for the symptomatic relief of seasonal allergic conjunctivitis, Winolap combines the rapid action of a selective H1-receptor antagonist with the long-term stability of a mast cell stabilizer. It is globally recognized as a premier clinical equivalent to innovator brands, providing targeted relief from ocular itching, redness, and swelling.

1. Manufacturer Profile: Sun Pharmaceutical Industries Ltd

Sun Pharma is the world’s fourth-largest specialty generic pharmaceutical company, renowned for its commitment to high-quality ophthalmic delivery systems and molecular purity.

  • Regulatory Standing: Produced in world-class facilities certified under WHO-GMP and inspected by the US FDA and EMA, ensuring that every 5 ml unit meets the highest safety benchmarks.
  • Innovation: Sun Pharma’s formulation of Winolap utilizes a specialized aqueous vehicle designed to match the natural pH and isotonicity of the eye, minimizing initial stinging upon application.

2. Composition & Active Ingredients

Each 1 ml of Winolap contains:

  • Active Ingredient: Olopatadine Hydrochloride IP equivalent to Olopatadine 1 mg (0.1% w/v).
  • Preservative: Benzalkonium Chloride 0.01% w/v (standard multi-dose stabilizer).
  • Vehicle: Sterile isotonic aqueous base (pH balanced).

3. Mechanism of Action: How It Works

Winolap utilizes a “Dual-Path” pharmacological strategy to neutralize the ocular allergic response.

A. Selective H1 Receptor Antagonism

Olopatadine is a potent, selective antagonist of histamine H1 receptors. Upon instillation, it rapidly competes with histamine at the receptor sites on the conjunctival surface. This action immediately stops the signals that cause intense itching and prevents the vascular leakage that leads to redness and watery eyes.

B. Mast Cell Stabilization

Unlike standard antihistamines, Winolap also acts as a mast cell stabilizer. it prevents the degranulation of mast cells, thereby inhibiting the release of additional inflammatory mediators like prostaglandins and leukotrienes. This comprehensive action prevents both the “early-phase” and “late-phase” allergic reactions, providing relief for up to 8–12 hours.

4. Therapeutic Indications

Winolap 5 ml is clinically indicated for:

  • Seasonal Allergic Conjunctivitis: Rapid relief of symptoms triggered by pollen, grass, and outdoor allergens.
  • Perennial Allergic Conjunctivitis: Managing ocular allergies caused by year-round triggers like dust mites and pet dander.
  • Ocular Redness and Swelling: Reducing the inflammatory appearance (hyperemia) of the eye associated with allergic triggers.

5. Clinical Comparison: Winolap vs. Patanol

Feature Winolap (Sun Pharma) Patanol (Innovator)
Active Ingredient Olopatadine 0.1% Olopatadine 0.1%
Bioequivalence **Confirmed** Reference Brand
Onset of Relief Within 5 Minutes Within 5 Minutes
Dosing Frequency Twice Daily Twice Daily

6. Dosing & Administration

Standard Dosing Protocol

  • Adults and Children (3+ Years): One drop in each affected eye twice daily (every 8 to 12 hours).

Application Guidelines

  1. Wash hands thoroughly.
  2. Tilt the head back and gently pull the lower eyelid to create a small pocket.
  3. Hold the dropper above the eye and instill one drop. **Do NOT let the dropper tip touch your eye or eyelashes.**
  4. Close the eye for 2 minutes and apply gentle pressure to the inner corner (tear duct).
  5. Discard the bottle 30 days after first opening to ensure sterility.

7. Precautions & Safety Warnings

  • Contact Lenses: Always remove contact lenses before using Winolap. Wait at least 15 minutes before re-inserting them, as the preservative can be absorbed by soft lenses.
  • Acute Relief: While Winolap works fast, it is not a “rescue” lubricant. If eyes are extremely dry or painful, consult a specialist.
  • Side Effects: Common localized effects include temporary blurred vision, dry eyes, or a mild “foreign body” sensation. These typically resolve within minutes.

8. Well-Researched FAQs

Q: Is Winolap safe for long-term use?

A: Yes, Winolap is clinically proven to be safe for use throughout the allergy season (usually up to 6–8 weeks) under medical guidance.

Q: Can I use Winolap for “Pink Eye” (Bacterial Conjunctivitis)?

A: No. Winolap is for allergic conditions only. It is not an antibiotic and will not treat bacterial or viral infections.

Q: Why does my mouth taste slightly bitter after use?

A: A small amount of the medication may drain through the tear duct into the throat. This is a common and harmless occurrence.

9. Official Regulatory References

  1. Sun Pharma Ophthalmic Index: Official Product Database
  2. DailyMed NIH: Olopatadine Hydrochloride Ophthalmic Solution Monograph.

Medical Disclaimer: This content is AI-generated for educational purposes based on clinical pharmaceutical data. It is NOT medical advice. Always consult a licensed healthcare professional for diagnosis and treatment.

Additional information

Brand Name

Molecule

Strength

5 ML

Medicine Form

Eye Drops

Packaging Type

Vial / Bottle

Pack Quantity

5 ML

Country Of Origin

India

Medicine Type

Generic

Rx Status

Rx (Prescription Medicine)

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Same molecule & strength

Other brands of Olopatadine 5 ML — the same active ingredient at the same strength, from a different manufacturer.

On this page
  1. Key facts
  2. Description
  3. Additional information
  4. Reviews (0)
  5. Same molecule

Content integrity

Medically reviewed by

Renu Meena, B.Pharm

Medical Content Writer

Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.

Last reviewed 14/07/2026

Shipping to your country

Options
Fast Delivery – Arrives in 7–12 Days, Express shipping (Arriving in 3-7 days )
Free over
USD $ 200.00